Finance
Hectorol maker reports 50% increase in sales
Published in Medical Letter on the CDC and FDA, November 30th, 2003
The company reported record quarterly sales for Hectorol (doxercalciferol) of $8.1 million, compared to Hectorol sales of $5.4 million for the first quarter of 2003, representing a 50% increase in the first quarter of 2004 compared with the same period in 2003.
The net loss for the first quarter of 2004 was $2.1 million, or $0.15 per common share, compared with a net loss for the first quarter of 2003 of $1.6 million, or $0.12 per common share. The company ended the first quarter of 2004 with a total of $14.2 million in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Salmonella
Serogroup-specific PCR assay for Salmonella enterica O:6,14 developed - Virology
Simian virus 2 and other simian picornaviruses represent new genus - Addiction Medicine
Social support reduces depressive symptoms in HIV-positive drug users - Obstetrics
Drinking before pregnancy increases risk of small-for-gestational-age birth - Poliovirus
Serial recombination found in type 1 wild-vaccine recombinant polioviruses - Typhus
Flying squirrel-associated typhus reported in United States - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
